Defective Products & Drug Recalls in VA Archives - Page 47 of 68 - Shapiro, Washburn & Sharp

Defective Hp Implant Lawsuits Mount; Outcomes Depend on Evidence of Patients’ Health Problems

Within weeks of the announcement that a widely used artificial hip was being recalled by its manufacturer because of high failure rates, patients who had experienced pain, mobility problems and health problems ranging from heart failure to flu-like symptoms began contacting personal injury, medical malpractice and defective products attorneys. Nearly 1,000 Americans who had DePuy’s…

read more

FDA Panel Recommends Halt in Use of Drug to Treat Breast Cancer

A panel of advisers to the U.S. Food and Drug Administration has recommended halting the use of Avastin (bevacizumab from Genentech) for treating breast cancer, pointing to studies showing the medication was not effective for that purpose, the Bellingham Herald reported. The recommendation followed two days of sometimes emotional testimony from doctors, patients and advocacy…

read more

Did Generic Drugmakers Get Relieved of Failure-to-Warn Liability?

In his latest post to our firm’s Norfolk Injuryboard blog, my colleague Rick Shapiro argues that federal lawmakers and the U.S. Food and Drug Administration must hold makers of generic medications and brand-name drugmakers to the same standards for warning patients about dangerous drug side effects. Rick’s concern over the unequal treatment of the pharmaceutical…

read more